Chia‐Ju Hsieh

California University of Pennsylvania — United States

Medicine · Health Sciences

25h-index1.9kcitations132works1.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Ovarian cancer diagnosis and treatment(38), PARP inhibition in cancer therapy(26), Parkinson's Disease Mechanisms and Treatments(18), Alzheimer's disease research and treatments(16), Neurological disorders and treatments(14)

Publications132 total

Supplemental Figure S2 from [<sup>18</sup>F]FluorThanatrace ([<sup>18</sup>F]FTT) PET Imaging of PARP-Inhibitor Drug-Target Engagement as a Biomarker of Response in Ovarian Cancer, a Pilot Study
2025Open Access
Supplemental Figure S3 from [<sup>18</sup>F]FluorThanatrace ([<sup>18</sup>F]FTT) PET Imaging of PARP-Inhibitor Drug-Target Engagement as a Biomarker of Response in Ovarian Cancer, a Pilot Study
2025Open Access
Supplemental Figure S5 from [<sup>18</sup>F]FluorThanatrace ([<sup>18</sup>F]FTT) PET Imaging of PARP-Inhibitor Drug-Target Engagement as a Biomarker of Response in Ovarian Cancer, a Pilot Study
2025Open Access
Supplemental Figure S1 from [<sup>18</sup>F]FluorThanatrace ([<sup>18</sup>F]FTT) PET Imaging of PARP-Inhibitor Drug-Target Engagement as a Biomarker of Response in Ovarian Cancer, a Pilot Study
2025Open Access
Supplemental Table S2 from [<sup>18</sup>F]FluorThanatrace ([<sup>18</sup>F]FTT) PET Imaging of PARP-Inhibitor Drug-Target Engagement as a Biomarker of Response in Ovarian Cancer, a Pilot Study
2025Open Access
Supplemental Figure S4 from [<sup>18</sup>F]FluorThanatrace ([<sup>18</sup>F]FTT) PET Imaging of PARP-Inhibitor Drug-Target Engagement as a Biomarker of Response in Ovarian Cancer, a Pilot Study
2025Open Access
Supplemental Figure S6 from [<sup>18</sup>F]FluorThanatrace ([<sup>18</sup>F]FTT) PET Imaging of PARP-Inhibitor Drug-Target Engagement as a Biomarker of Response in Ovarian Cancer, a Pilot Study
2025Open Access
Supplemental Table S1 from [<sup>18</sup>F]FluorThanatrace ([<sup>18</sup>F]FTT) PET Imaging of PARP-Inhibitor Drug-Target Engagement as a Biomarker of Response in Ovarian Cancer, a Pilot Study
2025Open Access
Mu-opioid receptor availability in patients with opioid use disorder treated with either methadone or buprenorphine
2025Open Access
198eP Single-cell profiling reveals functional polarization of neutrophil-associated circulating tumor cells in prostate cancer
ESMO Open·2025Open Access
Pilot Study of [11C]HY-2-15: A Mixed Alpha-Synuclein and Tau PET Radiotracer
Cells·2025· 1 citedOpen Access
[ <sup>11</sup> C]Carfentanil PET Whole-Body Imaging of μ-Opioid Receptors: A First in-Human Study
Journal of Nuclear Medicine·2025
Toward a Small-Molecule Antagonist Radioligand for Positron Emission Tomography Imaging of the Mu Opioid Receptor
ACS Chemical Neuroscience·2025· 1 cited
Author response for "The development of a PET Radiotracer for Imaging Alpha Synuclein Aggregates in Parkinson’s Disease"
2025
The development of a PET radiotracer for imaging alpha synuclein aggregates in Parkinson's disease
RSC Medicinal Chemistry·2025· 9 citedOpen Access
[ <sup>11</sup> C]Carfentanil PET Whole-Body Imaging of Mu-Opioid Receptors: A First In-Human Study
2025· 1 citedOpen Access
A Small-molecule Antagonist Radiotracer for Positron Emission Tomography Imaging of the Mu Opioid Receptor
2024· 1 citedOpen Access
Total-body imaging of mu-opioid receptors with [11C]carfentanil in non-human primates
European Journal of Nuclear Medicine and Molecular Imaging·2024· 11 citedOpen Access
Positron Emission Tomography with [18F]ROStrace Reveals Progressive Elevations in Oxidative Stress in a Mouse Model of Alpha-Synucleinopathy
International Journal of Molecular Sciences·2024· 10 citedOpen Access
Design and Synthesis of D3R Bitopic Ligands with Flexible Secondary Binding Fragments: Radioligand Binding and Computational Chemistry Studies
Molecules·2023· 1 citedOpen Access
page 1 of 7Next →

Frequent Co-authors

Robert H. Mach(23), Ing‐Tsung Hsiao(18), Kun‐Ju Lin(18), Tzu‐Chen Yen(16), Kuiying Xu(12), Shiaw‐Pyng Wey(12), Catherine Hou(10), Mei‐Ping Kung(8), Thomas J. A. Graham(8), Hsiaoju Lee(8), Chin‐Chang Huang(7), E. James Petersson(7), Aladdin Riad(7), Yi-Hsin Weng(6), Zsofia Lengyel‐Zhand(6), Mehran Makvandi(5), Wey‐Yil Lin(5), Kuo‐Lun Huang(5), Ji Youn Lee(5), Robert K. Doot(4)